April 25, 2019
Plaintiffs' attorneys who hid key witness testimony in the multidistrict opioid litigation were properly sanctioned by having that testimony blocked from a bellwether trial, drug companies told an Ohio federal court on Thursday.
April 18, 2019
An Ohio federal judge on Thursday said that drug companies in the multidistrict opioid litigation are apparently maneuvering to indefinitely delay a bellwether trial and that the idea isn't even worthy of consideration.
April 03, 2019
BakerHostetler earned its disqualification from key cases in the multidistrict opioid litigation because it crossed an "ethical line" by enlisting an attorney with potential inside information, local governments told an Ohio federal court Wednesday.
April 01, 2019
Endo Pharmaceuticals Inc. is decrying the disqualification of BakerHostetler from bellwether cases in the multidistrict opioid litigation, asserting that an Ohio federal judge "effectively became a witness" against the law firm during disqualification proceedings.
March 20, 2019
An Ohio federal judge on Wednesday disqualified BakerHostetler from two bellwether cases in the multidistrict opioid litigation, citing confidential information that a firm partner viewed while working at the U.S. Department of Justice.